NIMHANS launches endovascular innovation lab, unveils indigenous stroke device prototype ‘PARICHAY’

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription The View From India Looking at World Affairs from the Indian perspective. First Day First Show News and reviews from the world of cinema and streaming. Today's Cache Your download of the top 5 technology stories of the day. Data Point Decoding the headlines with facts, figures, and numbers Health Matters Ramya Kannan writes to you on getting to good health, and staying there The Hindu On Books Books of the week, reviews, excerpts, new titles and features. Marking a significant step towards developing home-grown neurovascular technologies, the National Institute of Mental Health and Neurosciences (NIMHANS) last week launched India’s first dedicated Endovascular Research and Innovation (EVRI) laboratory. The alpha prototype of an indigenous mechanical thrombectomy device for acute stroke intervention was also unveiled on the occasion. The laboratory, funded by the Science and Engineering Research Board (SERB), now the Anusandhan National Research Foundation (ANRF), Government of India, was inaugurated by NIMHANS director Prabha S. Chandra during a workshop titled ‘Atmanirbhar Bharat: Self-Reliant India in Neuroscience – Intellectual Property Rights (IPR)’, held at the institute. A key highlight of the event was the unveiling of the alpha prototype of ‘PARICHAY’, an indigenous mechanical thrombectomy device designed for the treatment of acute ischemic stroke. The prototype was unveiled by B. N. Gangadhar, former director of NIMHANS and former chairman of the National Medical Commission. Doctors said mechanical thrombectomy devices are used to remove blood clots from blocked arteries in the brain during an acute ischemic stroke. The procedure is time-critical and can significantly improve outcomes if performed promptly. The development of an indigenous device is expected to contribute to making advanced stroke care more accessible and affordable. The EVRI Laboratory has been established to focus on the research, design, development, and translation of neurovascular technologies, with an emphasis on reducing dependence on imported medical devices and strengthening indigenous innovation in advanced healthcare. Speaking on the occasion, Dr. Chandra underscored the need for innovation-driven healthcare solutions and greater self-reliance in high-end medical technologies. The workshop on IPR was organised by the Department of Neurosurgery, NIMHANS, in collaboration with the NIMHANS Incubation Centre and the Health and Intellectual Pr